fig10
![Influence of chlorpyrifos oxon on the development and progression of Alzheimer's disease in amyloid precursor protein transgenic mice](https://image.oaes.cc/f317a5de-62d1-4930-9458-5ef9656e80fe/111.fig.10.png)
Figure 10. Treatment of amyloid precursor protein (APP) mice with galantamine partially attenuates the effects of chlorpyrifos oxon (CPO) on amyloid β (Aβ peptide levels and plaque load. Weaned APP mice (3-week of age) were treated with CPO (1 mg/kg) or CPO + galantamine (2 mg/kg/day, i.m.) and examined for Aβ peptide levels (a) and amyloid load (b) values are shown as the mean ± standard error of the mean, and n = 12. *Statistically significant (P < 0.05)